Venous Thromboembolism: all 708 studies

Page 2 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.

• Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home HospitalizationRecruitingNCT06110949
• Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)RecruitingNCT06057844Not applicable
• Evaluation of Chemical Venous Thromboembolism Prophylaxis in TraumaEnrolling by invitationNCT06025162
• Study of Low Molecular Weight HeparinsRecruitingNCT06020560Phase 4
• Venous Thromboembolism in Primary Pancreatic Tumour ResectionRecruitingNCT05964621
• Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant TumorsRecruitingNCT05939960
• VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic TherapyRecruitingNCT05920343Phase 2/3
• A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)Not yet recruitingNCT05900388
• Supplemental Oxygen in Pulmonary Embolism (SO-PE)RecruitingNCT05891886Early Phase 1
• Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set StudyRecruitingNCT05881798
• Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following NeurosurgeryRecruitingNCT05860790
• Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous ThromboembolismEnrolling by invitationNCT05794165Phase 2
• Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French WestRecruitingNCT05773638
• PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolismRecruitingNCT05756244
• THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein ThrombosisRecruitingNCT05701917Not applicable
• Venous Thromboembolism Prevention in Outpatients With GliomaRecruitingNCT05683808Phase 2
• Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking AntiplateletsRecruitingNCT05627375Phase 3
• GEKO Venous Thromboembolism Prevention StudyRecruitingNCT05476913Not applicable
• NOACs Use in AF or VTE (SUNSHINE Registry)RecruitingNCT05378308
• DOAC in Chinese Patients With Atrial FibrillationRecruitingNCT05378035
• Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical PatientsRecruitingNCT05347550Not applicable
• Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement StudyRecruitingNCT05306821Not applicable
• Platelet FcGammaRIIa and Risk of Venous Thromboembolism in CancerRecruitingNCT05240508
• Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort StudyRecruitingNCT05229471
• AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative NeoplasmsRecruitingNCT05198960Phase 3
• Primary Thromboprophylaxis in Patients With Malignancy and Central Venous CathetersRecruitingNCT05029063Phase 3
• Catheter-Related Early Thromboprophylaxis With Enoxaparin StudiesRecruitingNCT04924322Phase 2/3
• Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver CirrhosisRecruitingNCT04874428Phase 1
• Warfarin Patient Self-management Implementation in the US Healthcare SystemRecruitingNCT04766216Not applicable
• Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux LevelsRecruitingNCT04539301
• Statins for Venous Event Reduction in Patients With Venous ThromboembolismRecruitingNCT04319627Phase 3
• Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint ArthroplastyRecruitingNCT04295486Phase 2
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary EmbolismRecruitingNCT04263038Phase 4
• Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)RecruitingNCT04257487Phase 3
• CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous ThromboembolismRecruitingNCT04211181Not applicable
• Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava FiltersRecruitingNCT04066764Phase 3
• Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)RecruitingNCT04042155
• Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel DiseaseRecruitingNCT03935451Early Phase 1
• Ongoing Registry of Treatment of Venous ThromboembolismRecruitingNCT03881345
• Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous ThromboembolismRecruitingNCT03781531
• Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)RecruitingNCT03728166Not applicable
• Pregnancy and Risk of Venous ThromboembolismRecruitingNCT03659708Not applicable
• PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)RecruitingNCT03559114Phase 3
• Swedish Multicenter Trial of Outpatient Prevention of Leg ClotsRecruitingNCT03259204Not applicable
• LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyEnrolling by invitationNCT03244020Phase 4
• Caprini Score in Venous Surgery: a Prospective Cohort StudyRecruitingNCT03041805
• The China Pulmonary Thromboembolism Registry StudyRecruitingNCT02943343
• Computerized Registry of Patients With Venous Thromboembolism (RIETE)RecruitingNCT02832245
• START-Register: Survey on Anticoagulated Patients RegisterRecruitingNCT02219984
• VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTERecruitingNCT02156401
• Filter Initial & Long Term Evaluation After Placement and Retrieval RegistryRecruitingNCT01158482
• A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult ParticipantsCompletedNCT06454630Phase 2Results posted
• A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotTerminatedNCT05966740Results posted
• Treatment Patterns Among Patients With Venous Thromboembolism in the United StatesCompletedNCT05795062Results posted
• A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult ParticipantsCompletedNCT05618808Phase 2Results posted
• Xarelto for Thromboprophylaxis After Total Hip and Total Knee ArthroplastyCompletedNCT05449327Not applicableResults posted
• Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant UseCompletedNCT05351749Not applicableResults posted
• Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in KoreaCompletedNCT05022563Results posted
• The Incidence of Venous Thromboembolism in Atopic DermatitisCompletedNCT04969653Results posted
• Use of Tranexamic Acid in Reduction MammoplastyCompletedNCT04947514Phase 4Results posted
• OsciPulse Device for the Prevention of VTECompletedNCT04625673Not applicableResults posted
• Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCTCompletedNCT04504318Phase 1/2Results posted
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialCompletedNCT04409834Phase 4Results posted
• Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant ChemotherapyCompletedNCT04352439Phase 4Results posted
• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous ThromboembolismCompletedNCT04168203Phase 4Results posted
• PET Fibrin Imaging of DVT and PETerminatedNCT04022915Phase 1Results posted
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyCompletedNCT03835780Results posted
• Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee ReplacementCompletedNCT03812328Phase 2Results posted
• ThRombosis ExclUsion STudyTerminatedNCT03477968Results posted
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic TraumaCompletedNCT03339349Phase 2Results posted
• Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous ThromboembolismCompletedNCT03266783Phase 4Results posted
• Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery PatientsCompletedNCT03251963Phase 2Results posted
• Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive SurgeryCompletedNCT03212365Phase 2Results posted
• Comparison of Oral Anticoagulants for Extended VEnous ThromboembolismTerminatedNCT03196349Phase 4Results posted
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaTerminatedNCT03195010Phase 2Results posted
• Apixaban for the Treatment of Venous Thromboembolism in Patients With CancerCompletedNCT03045406Phase 3Results posted
• Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous ThromboembolismCompletedNCT03044574Not applicableResults posted
• PREvention of VENous ThromboEmbolism Following Radical ProstatectomyTerminatedNCT03006562Phase 4Results posted
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose HeparinCompletedNCT02970032Early Phase 1Results posted
• Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple MyelomaCompletedNCT02958969Phase 4Results posted
• Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in EuropeCompletedNCT02943993Results posted
• Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary EmbolismCompletedNCT02923115Phase 1/2Results posted
• STAT-STatin and Aspirin in TraumaTerminatedNCT02901067Phase 2Results posted
• RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual BleedingCompletedNCT02829957Phase 2/3Results posted
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)CompletedNCT02798471Phase 3Results posted
• A Different Approach to Preventing ThrombosisCompletedNCT02774265Phase 3Results posted
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous ThromboembolismCompletedNCT02596230Results posted
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedNCT02585713Phase 3Results posted
• Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot StudyCompletedNCT02559856Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsCompletedNCT02555878Phase 3Results posted
• Apixaban for the Acute Treatment of Venous Thromboembolism in ChildrenCompletedNCT02464969Phase 4Results posted
• Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma PatientsCompletedNCT02412982Phase 4Results posted
• Enoxaparin Metabolism in Reconstructive Surgery PatientsCompletedNCT02411292Phase 2Results posted
• Education Bundle to Decrease Patient Refusal of VTE ProphylaxisCompletedNCT02402881Not applicableResults posted
• Aspirin and Enoxaparin for VTE in TraumaTerminatedNCT02396732Phase 4Results posted
• Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic MalignancyCompletedNCT02366871Phase 2Results posted
• Statin Use in Patients With Acute VTETerminatedNCT02331095Early Phase 1Results posted
• EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous ThrombosisCompletedNCT02309411Phase 2Results posted

← Venous Thromboembolism overview